• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
TAO Linlin, HUO Meirong, XU Wei. Advances in the research of protein nanocarrier materials[J]. Journal of China Pharmaceutical University, 2020, 51(2): 121-129. DOI: 10.11665/j.issn.1000-5048.20200201
Citation: TAO Linlin, HUO Meirong, XU Wei. Advances in the research of protein nanocarrier materials[J]. Journal of China Pharmaceutical University, 2020, 51(2): 121-129. DOI: 10.11665/j.issn.1000-5048.20200201

Advances in the research of protein nanocarrier materials

More Information
  • Nanotechnology has brought new strategies in the area of pharmaceutical sciences, especially in the drug delivery system. Among them, the application of protein as drug carriers has drawn extensive attention. A wide variety of proteins that have been used fordrug delivery system including the common animal- and plant-basedproteins, as well as the recombinant protein nanoparticles, which possess many advantages such as biocompatibility, biodegradability, low antigenicity, higher stability and drug loading property. This system is of great significance in the fields of clinical treatment, especially targeted therapy of tumors. In this paper, the fabrication of nanoparticles from animal, botanical, and recombinant proteins are described. And then, trend of development in protein-based nanocarriers is also prospected.
  • [1]
    Lohcharoenkal W,Wang L,Chen YC,et al.Protein nanoparticles as drug delivery carriers for cancer therapy[J].Bio Med Res Inter,2014,2014:1-12.
    [2]
    An FF,Zhang XH.Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery[J].Theranostics,2017,7(15):3667-3689.
    [3]
    Larsen MT,Kuhlmann M,Hvam ML,et al.Albumin-based drug delivery:harnessing nature to cure disease[J].Mol Cell Ther,2016,4(1):3-15.
    [4]
    IchimizuS,Watanabe H,Maeda H,et al.Design and tuning of a cell-penetrating albumin derivative as a versatile nanovehicle for intracellular drug delivery[J].J Control Release,2018,277:23-34.
    [5]
    Tan YL,Ho HK.Navigating albumin-based nanoparticles through various drug delivery routes[J].Drug Discov Today,2018,23(5):1108-1114.
    [6]
    Van WA,Sontum PC,Healey A,et al.Acoustic Cluster Therapy(ACT)enhances the therapeutic efficacy of paclitaxel and abraxane for treatment of human prostate adenocarcinoma in mice[J].J Control Release,2016,236:15-21.
    [7]
    Jin Z,Youhui S,Min C,et al.Albumin fusion of interleukin-28B:production and characterization of its biological activities and protein stability[J].PLoS One,2013,8(5):e64301.
    [8]
    Tang B,Qian Y,Gou Y,et al.VE-albumin core-shell nanoparticles for paclitaxel delivery to treat MDR breast cancer[J].Molecules,2018,23(11):2760-2770.
    [9]
    Chen Q,Wang X,Wang C,et al.Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy[J].ACS Nano,2015,9:5223-5233.
    [10]
    Ruan C,Liu L,Lu Y,et al.Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma[J].Acta Pharm Sin B,2018,8(1):85-96.
    [11]
    Chen Q,Liang C,Wang C,et al.An imagable and photothermal “Abraxane-like” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors[J].Adv Mater,2015,27(5):903-910.
    [12]
    Jain A,Sharma G,Ghoshal G,et al.Lycopene loaded whey protein isolate nanoparticles:an innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity[J].Int J Pharm,2018,546(1/2):97-105.
    [13]
    Jiang S,Cheng J,Jiang Z,et al.Effect of heat treatment on physicochemical and emulsifying properties of polymerized whey protein concentrate and polymerized whey protein isolate[J].LWT,2018,98:134-140.
    [14]
    Zhao C,Shen X,Guo M.Stability of lutein encapsulated whey protein nano-emulsion during storage[J].PLoS One,2018,13(2):e0192511.
    [15]
    Lv L,Fu C,Zhang F,et al.Thermally-induced whey protein isolate-daidzein co-assemblies:protein-based nanocomplexes as an inhibitor of precipitation/crystallization for hydrophobic drug[J].Food Chem,2019,275:273-281.
    [16]
    Jayaprakasha GK,Murthy KNC,Patil BS.Enhanced colon cancer chemoprevention of curcumin by nanoencapsulation with whey protein[J].Eur J Pharmacol,2016,789:291-300.
    [17]
    Mohammadian M,Salami M,Momen S,et al.Enhancing the aqueous solubility of curcumin at acidic condition through the complexation with whey protein nanofibrils[J].Food Hydrocoll,2019,87:902-914.
    [18]
    Luo T,David MA,Dunshee LC,et al.Thermoresponsive elastin-b-collagen-like peptide bioconjugate nanovesicles for targeted drug delivery to collagen-containing matrices[J].Biomacromolecules,2017,18(8):2539-2551.
    [19]
    Gil CSB,Gil VSB,Carvalho SM,et al.Recycled collagen films as biomaterials for controlled drug delivery[J].New J Chem,2016,40(10):8502-8510.
    [20]
    Li YM,Huang YD,Xiang Q,et al.Preparation and in vitro/in vivo pharmacological studies of bFGF/collagen composite sponge[J].J China Pharm Univ(中国药科大学学报),2010,41(1):35-39.
    [21]
    Lam PL,Kok HL,Bian ZX,et al.Collagen-silica nanocomposites as dermal dressings preventing infection in vivo[J].Mater Sci Eng C,2018,93:170-177.
    [22]
    Mondal S, Hoang G, Manivasagan P, et al. Rapid microwave-assisted synthesis of gold loaded hydroxyapatite collagen nano-bio materials for drug delivery and tissue engineering application[J].Ceram Int,2019,45(3):2977-2988.
    [23]
    Crivelli B, Perteghella S, Bari E, et al. Silk nanoparticles:from inert supports to bioactive natural carriers for drug delivery[J].Soft Matter,2018,14(4):546-557.
    [24]
    Mao B,Liu C,Zheng W,et al.Cyclic cRGDfk peptide and chlorin e6 functionalized silk fibroin nanoparticles for targeted drug delivery and photodynamic therapy[J].Biomaterials,2018,161:306-320.
    [25]
    Montalbán MG,Coburn JM,Lozano-Pérez AA,et al.Production of curcumin-loaded silk fibroin nanoparticles for cancer therapy[J].Nanomaterials,2018,8(2):126-143.
    [26]
    Suktham K,Koobkokkruad T,Wutikhun T,et al.Efficiency of resveratrol-loaded sericin nanoparticles:promising bionanocarriers for drug delivery[J].Int J Pharm,2018,537(1/2):48-56.
    [27]
    Wu P,Liu Q,Li R,et al.Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery[J].ACS Appl Mater Interfaces,2013,5(23):12638-12645.
    [28]
    Tallian C,Herrero-Rollett A,Stadler K,et al.Structural insights into pH-responsive drug release of self-assembling human serum albumin-silk fibroin nanocapsules[J].Eur J Pharm Biopharm,2018,133:176-187.
    [29]
    Lee NK,Lee EJ,Kim S,et al.Ferritin nanocage with intrinsically disordered proteins and affibody:a platform for tumor targeting with extended pharmacokinetics[J].J Control Release,2017,267:172-180.
    [30]
    Truffi M,Fiandra L,Sorrentino L,et al.Ferritin nanocages:a biological platform for drug delivery,imaging and theranostics in cancer[J].Pharmacol Res,2016,107:57-65.
    [31]
    He D,Marles-Wright J.Ferritin family proteins and their use in bionanotechnology[J].N Biotechnol,2015,32(6):651-657.
    [32]
    Khoshnejad M,Parhiz H,Shuvaev VV,et al.Ferritin-based drug delivery systems:hybrid nanocarriers for vascular immunotargeting[J].J Control Release,2018,282:13-24.
    [33]
    Ki MR,Nguyen TKM,Jun HS,et al.Biosilica-enveloped ferritin cage for more efficient drug deliveries[J].Process Biochem,2018,68:182-189.
    [34]
    Ferraro G,Petruk G,Maiore L,et al.Caged noble metals:encapsulation of a cytotoxic platinum(II)-gold(I)compound within the ferritin nanocage[J].Int J Biol Macromol,2018,115:1116-1121.
    [35]
    Tong H,Zhang W.Ultrasound-nanobubble-mediated collaborative therapy for glioma by dual targeting ferritin nanocages carrying curcumin[J].Nanomed Nanotechnol,2018,14(5):1813.
    [36]
    Monti DM,Ferraro G,Merlino A.Ferritin-based anticancer metallodrug delivery:crystallographic,analytical and cytotoxicity studies[J].Nanomedicine,2019,20:101997.
    [37]
    Falvo E,Tremante E,Fraioli R,et al.Antibody-drug conjugates:targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin[J].Nanoscale,2013,5(24):12278-12285.
    [38]
    Fan K,Jia X,Zhou M,et al.Ferritin nanocarrier traverses the blood brain barrier and kills glioma[J].ACS Nano,2018,12(5):4105-4115.
    [39]
    Liu X,Suo R,Xiong SL,et al.HDL drug carriers for targeted therapy[J].Clin Chim Acta,2013,415:94-100.
    [40]
    Mo ZC,Ren K,Liu X,et al.A high-density lipoprotein-mediated drug delivery system[J].Adv Drug Deliv Rev,2016,106:132-147.
    [41]
    Liu C,Li SN,Wang Y,et al.Advances in research of high density lipoprotein and low density lipoprotein nano-complexes as anti-cancer drug targeting carriers[J].Chin J New Drugs(中国新药杂志),2017,26(3):285-290.
    [42]
    Zhang Y,Sun T,Jiang C.Biomacromolecules as carriers in drug delivery and tissue engineering[J].Acta Pharm Sin B,2017,8(1):34-50.
    [43]
    Kader A,Pater A.Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells[J].J Control Release,2002:29-44.
    [44]
    Huntosova V,Buzova D,Petrovajova D,et al.Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells[J].Int J Pharm,2012,436(1/2):463-471.
    [45]
    Reynolds L, Mulik RS, Wen X, et al. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells[J].Nanomedicine,2014,9(14):2123-2141.
    [46]
    Tian J,Xu S,Deng H,et al.Fabrication of self-assembled chitosan-dispersed LDL nanoparticles for drug delivery with a one-step green method[J].Int J Pharm,2017,517(1/2):25-34.
    [47]
    Elzoghby AO,Elgohary MM,Kamel NM.Implications of protein- and peptide-based nanoparticles as potential vehicles for anticancer drugs[J].Adv Protein Chem Str,2015,98:169-221.
    [48]
    Singh S, Gaikwad KK, Lee M, et al. Microwave-assisted micro-encapsulation of phase change material using zein for smart food packaging applications[J].J Therm Anal Calorim,2018,131(3):2187-2195.
    [49]
    Li S,Wang X,Li W,et al.Preparation and characterization of a novel conformed bipolymer paclitaxel-nanoparticle using tea polysaccharides and zein[J].Carbohydr Polym,2016,146:52-57.
    [50]
    Wang H, Zhang X, Zhu W, et al. Self-assembly of zein-based microcarrier system for colon-targeted oral drug delivery[J].Ind Eng Chem Res,2018,57(38):12689-12699.
    [51]
    Mocanu G, Nichifor M, Sacarescu L. Dextran based polymeric micelles as carriers for delivery of hydrophobic drugs[J].Curr Drug Deliv,2017,14(3):406-415.
    [52]
    Labib G.Overview on zein protein:a promising pharmaceutical excipient in drug delivery systems and tissue engineering[J].Expert Opin Drug Deliv,2018,15(1):65-75.
    [53]
    Wang P,Tao H,Wu F,et al.Effect of frozen storage on the foaming properties of wheat gliadin[J].Food Chem,2014,164:44-49.
    [54]
    Malekzad H,Mirshekari H,SahandiZangabad P,et al.Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems[J].Crit Rev Biotechnol,2018,38(1):47-67.
    [55]
    Lopes D,Nunes C,Martins MC,et al.Eradication of helicobacter pylori:past,present and future[J].J Control Release,2014,189:169-186.
    [56]
    Sonekar S,Mishra MK,Patel AK,et al.Formulation and evaluation of folic acid conjugated gliadin nanoparticles of curcumin for targeting colon cancer cells[J].J Appl Pharm Sci,2016,6(10):68-74.
    [57]
    Joye IJ,Nelis VA,Mcclements DJ.Gliadin-based nanoparticles:stabilization by post-production polysaccharide coating[J].Food Hydrocoll,2015,43:236-242.
    [58]
    Tang CH.Nanostructured soy proteins:fabrication and applications as delivery systems for bioactives[J].Food Hydrocoll,2019,91:92-116.
    [59]
    Tansaz S, Singh R, Cicha I, et al. Soy protein-based composite hydrogels:physico-chemical characterization and in vitro cytocompatibility[J].Polymers,2018,10(10):1159-1176.
    [60]
    Pujara N,Jambhrunkar S,Wong KY,et al.Enhanced colloidal stability,solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate[J].J Colloid Interface Sci,2017,488:303-308.
    [61]
    Cheng X,Qin J,Wang X,et al.Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo[J].Eur J Pharm Biopharm,2018,128:247-258.
    [62]
    Cheng X,Wang X,Cao Z,et al.Folic acid-modified soy protein nanoparticles for enhanced targeting and inhibitory[J].Mat Sci Eng:C,2017,71:298-307.
    [63]
    Elzoghby AO,Elgohary MM,Kamel NM.Implications of protein- and peptide-based nanoparticles as potential vehicles for anticancer drugs[J].Adv Protein Chem Struct Biol,2015,98:169-221.
    [64]
    Wang ZT,Ma NN.The pharmaceutical application research progress of industrial production of human serum albumin[J].China Mod Med(中国当代医药),2017,24(19):11-14.
    [65]
    Sharma A, Kaur A, Jain UK, et al. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer,HT-29 cells[J].Colloid Surface B,2017,155:200-208.
    [66]
    Zhang WL,Gu X,Bai H,et al.Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug[J].Int J Pharm,2010,391(1/2):313-321.
    [67]
    Zhang F,Wang X,Xu X,et al.Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells[J].Eur J Pharm Sci,2016,92:11-21.
    [68]
    Xu L,Tremblay ML,Orrell KE,et al.Nanoparticle self-assembly by a highly stable recombinant spider wrapping silk protein subunit[J].FEBS Lett,2013,587(19):3273-3280.
    [69]
    Doblhofer E,Scheibel T.Engineering of recombinant spider silk proteins allows defined uptake and release of substances[J].J Pharm Sci,2015,104(3):988-994.
  • Related Articles

    [1]MU Yao, ZHAO Huimin, LIU Haochen, LIU Xiaoquan. Advances in drug development for Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(6): 816-825. DOI: 10.11665/j.issn.1000-5048.2024010202
    [2]XING Xuyang, WANG Xiaochun, HE Wei. Advances in research on tumor immunotherapy and its drug development[J]. Journal of China Pharmaceutical University, 2021, 52(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20210102
    [3]MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301
    [4]CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203
    [5]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [6]YIN Lei, WANG Ying, CHEN Song, GAO Xiangdong. Advances of glucagon-like peptide-1 receptor agonists in the treatment of nervous system diseases[J]. Journal of China Pharmaceutical University, 2014, 45(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20140401
    [7]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [8]WANG Juan, LIAO Hong. Advances in drug research and development through directed differentiation of stem cells[J]. Journal of China Pharmaceutical University, 2011, 42(3): 193-197.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80.
  • Cited by

    Periodical cited type(6)

    1. 金伟斌,陈礼峰,唐倩倩,顾晓风. 顶空气相色谱法测定生脉注射液中甲醛和乙醛的含量. 中国合理用药探索. 2022(06): 115-120 .
    2. 李浩宇,唐宝强,何东升,涂家生. 气相色谱法测定药用辅料聚西托醇1000中的残留杂质. 中国药科大学学报. 2022(03): 293-299 . 本站查看
    3. 王贺,钱利武,阚红卫. 药用辅料监管法规、质量标准现状分析及应对措施. 中南药学. 2022(08): 1937-1941 .
    4. 庞丽然,贺丞,杜力,刘国芳. 重组蛋白中吐温80含量硫氰酸铵钴显色检测法的改进及验证. 中国生物制品学杂志. 2021(09): 1111-1113+1119 .
    5. 郑永强,付俊伟,朱慧敏,陶晓军. 一种用于实现脑靶向的负载长春新碱抗肿瘤纳米药物制剂的制备及表征. 肿瘤药学. 2021(05): 547-553 .
    6. 黄婧,吴宏伟. 依诺沙星滴眼液辅料及药包材相容性研究. 中国现代应用药学. 2021(22): 2802-2806 .

    Other cited types(2)

Catalog

    Article views (1243) PDF downloads (1930) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return